Bastion Therapeutics Overview
- Year Founded
-
2018
- Status
-
Out of Business
- Employees
-
9
- Latest Deal Type
-
Out of Business
Bastion Therapeutics General Information
Description
Operator of a drug research unit intended to design anti-inflammatory cell therapies. The company's therapies reduce neuroinflammation at key sites within a patient's central nervous system, protecting neurons and increasing synaptic connectivity, enabling patients to prevent a decline in cognitive function.
Contact Information
Website
www.bastion-tx.comCorporate Office
- Berg Kaprow Lewis Llp
- 35 Ballards Lane
- London N3 1XW
- England, United Kingdom
Corporate Office
- Berg Kaprow Lewis Llp
- 35 Ballards Lane
- London N3 1XW
- England, United Kingdom
Bastion Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Out of Business | 19-May-2026 | Completed | Out of Business | |||
| 7. Seed Round | 16-Feb-2024 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 01-Jan-2023 | Completed | Generating Revenue | |||
| 5. Seed Round | 01-Sep-2022 | Completed | Generating Revenue | |||
| 4. Seed Round | Cancelled | Generating Revenue | ||||
| 3. Seed Round | 11-Nov-2020 | Completed | Generating Revenue | |||
| 2. Grant | 17-Aug-2020 | $586K | $91K | Completed | Generating Revenue | |
| 1. Seed Round | 13-May-2019 | $91K | $91K | Completed | Generating Revenue |
Bastion Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 403,000 | $0.000013 | $0.16 | $0.16 | 1x | $0.16 | 2.06% | |
| Ordinary | 1,232,000 | $0.000013 | $0.07 | $0.07 | 1x | $0.07 | 6.3% |
Bastion Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Bastion Therapeutics Patents
Bastion Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202113673-D0 | Targeted cell therapies | Inactive | 24-Sep-2021 | ||
| GB-202113674-D0 | Targeted cell therapies | Inactive | 24-Sep-2021 | ||
| WO-2023047124-A2 | Targeted cell therapies | Inactive | 24-Sep-2021 | ||
| WO-2023047124-A3 | Targeted cell therapies | Inactive | 24-Sep-2021 | ||
| WO-2023047125-A1 | Targeted cell therapies | Inactive | 24-Sep-2021 | A61K40/22 |
Bastion Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Bastion Therapeutics FAQs
-
When was Bastion Therapeutics founded?
Bastion Therapeutics was founded in 2018.
-
Where is Bastion Therapeutics headquartered?
Bastion Therapeutics is headquartered in London, United Kingdom.
-
What is the size of Bastion Therapeutics?
Bastion Therapeutics has 9 total employees.
-
What industry is Bastion Therapeutics in?
Bastion Therapeutics’s primary industry is Drug Discovery.
-
Is Bastion Therapeutics a private or public company?
Bastion Therapeutics is a Private company.
-
What is Bastion Therapeutics’s current revenue?
The current revenue for Bastion Therapeutics is .
-
How much funding has Bastion Therapeutics raised over time?
Bastion Therapeutics has raised $1.61M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
